SEC Form 4 · accession 0001022079-19-000021
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine T. Doherty
Officer — SVP, Group Exec. Clin. Fran.
Period of report
Feb 18, 2019
Accepted (ET)
Feb 20, 2019 · 6:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 18, 2019 | A | 3,348 | $0.00 | A | 71,289 | D | |
| Common StockF2 | holding | — | — | — | 3,924 | I | 401(k)/SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualifed Stock Option (right to buy)F3 | $86.63 | Feb 18, 2019 | A | 40,765 | A | — | Feb 18, 2029 | Common Stock | 40,765 | 40,765 | D |
Explanation of responses
- F1Represents an award of restricted share units.
- F2These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F3The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.